Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLAB | Common Stock | Options Exercise | $196K | +2K | +26.62% | $97.78 | 9.51K | Oct 20, 2021 | Direct | |
transaction | MLAB | Common Stock | Sale | -$620K | -2K | -21.02% | $309.86 | 7.51K | Oct 20, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLAB | Non Qualified Stock Option | Exercise of in-the-money or at-the-money derivative security | $0 | -2K | -6.06% | $0.00 | 31K | Oct 20, 2021 | Common Stock | 2K | $97.78 | Direct | F1 |
Id | Content |
---|---|
F1 | 1/5 exercisable on each anniversary date of the 04-01-2016 grant date |
F2 | Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 |